An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Tekla Healthcare Investors (NYSE: HQH) has declared a distribution of $0.40 per share. The distribution record date is August 25, 2023, and the payable date is September 29, 2023. The Fund intends to make quarterly distributions at a rate of 2% of the Fund’s net assets. The distribution will be paid in newly issued shares of the Fund, valued at the lower of the net asset value or market price on September 21, 2023.
Positive
None.
Negative
None.
BOSTON--(BUSINESS WIRE)--
On August 15, 2023, Tekla Healthcare Investors declared a distribution of $0.40 per share. The record date for the distribution is August 25, 2023 and the payable date is September 29, 2023. The Fund will trade ex-distribution on August 24, 2023.
Under its distribution policy, the Fund intends to make quarterly distributions at a rate of 2% of the Fund’s net assets. Therefore, when the net assets of the Fund are down, the distribution per share amount will decrease and when the net assets are up, the distribution amount per share will increase. This distribution will automatically be paid in newly issued shares of the Fund unless otherwise instructed by the shareholder. The shares will be valued at the lower of the net asset value or market price on the pricing date, September 21, 2023. Fractional shares will generally be settled in cash, except for registered shareholders with book entry accounts at the transfer agent who will have whole and fractional shares added to their account.
Shareholders may request to be paid in cash instead of shares by responding to the bank, brokerage or nominee who holds the shares if the shares are in “street name” or by filling out an election card received from Computershare Investor Services shortly after the record date if the shares are in registered form. The bank, brokerage or nominee who holds the shares must advise the Depository Trust Company ("DTC") as to their full and fractional share requirements by September 20, 2023. Written notification for the election of cash instead of stock by registered shareholders must be received by Computershare Investor Services prior to September 20, 2023.
Tekla Healthcare Investors (NYSE: HQH) is a closed-end fund that invests in public and private companies in the healthcare industry. Tekla Capital Management LLC, based in Boston, serves as Investment Adviser to the Fund. Shares of the Fund can be purchased on the New York Stock Exchange through any securities broker.
Information regarding the Fund and Tekla Capital Management LLC can be found at www.teklacap.com.
Please contact Destra Capital Advisors, the Fund’s marketing and investor support services agent, at HQH@destracapital.com or call (877) 855-3434 if you have any questions regarding HQH.
What is the distribution amount declared by Tekla Healthcare Investors?
The distribution declared by Tekla Healthcare Investors is $0.40 per share.
When is the distribution record date and payable date?
The distribution record date is August 25, 2023, and the payable date is September 29, 2023.
What is the distribution rate of the Fund?
The Fund intends to make quarterly distributions at a rate of 2% of the Fund’s net assets.
How will the distribution be paid?
The distribution will be automatically paid in newly issued shares of the Fund, valued at the lower of the net asset value or market price on September 21, 2023.
Where can shares of the Fund be purchased?
Shares of the Fund can be purchased on the New York Stock Exchange through any securities broker.
Who is the Investment Adviser to the Fund?
Tekla Capital Management LLC, based in Boston, serves as the Investment Adviser to the Fund.
Who can be contacted for questions regarding HQH?
For any questions regarding HQH, please contact Destra Capital Advisors, the Fund’s marketing and investor support services agent, at HQH@destracapital.com or call (877) 855-3434.
tekla life sciences investors is a closed-ended equity mutual fund launched and managed by tekla capital management llc. the fund invests in public equity markets across the globe. it seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. the fund primarily invests in growth stocks of small cap companies. it employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. the fund benchmarks the performance of its portfolio against the nasdaq biotech index and the s&p 500 index. it was form
